Lexicon Pharmaceuticals
Home
Contact Us
Site Map
About Us
About Us Home
Management Team
Board of Directors
Development Team
Locations
Contact Us
History
Pipeline
Drug Pipeline Home
Our Goal
Therapeutic Areas
Drug Development Team
Clinical Trials
Publications
Discovery
Discovery Home
Discovery Process
Technology
Genome5000
Medicinal Chemistry
Biotherapeutics
Patents
Academic Access
Technology Licensing
Alliances
Alliances Home
Current Alliances
Technology Licensing
Careers
Careers Home
Opportunities
Our Culture
Benefits
Community Involvement
The Woodlands
Princeton
Awards and Recognition
News
News Home
Media Inquiries
Investors
Investors Home
Media
Events
Stock Quote
SEC Filings
Annual Reports
Corporate Governance
Request Information
News Home
Media Inquiries
Subscribe
Press Releases
Filter
Display #
5
10
15
20
25
30
50
100
All
02/03/2004
Lexicon Genetics to Discuss Fourth Quarter and Year End 2003 Financial Results on Webcast and Conference Call
01/20/2004
Piper Jaffray Health Care Conference to Webcast Lexicon Genetics Presentation
01/13/2004
Lexicon Genetics has Initiated More Than 40 Drug Discovery Programs from its Genome5000(TM) Program
01/06/2004
Lexicon Genetics to Present at the 22nd Annual JPMorgan Healthcare Conference
12/22/2003
Lexicon Genetics Grants License to AstraZeneca for Patented Gene Targeting Technology
12/18/2003
Lexicon Genetics and Bristol-Myers Squibb Establish Neuroscience Alliance for Drug Development
12/03/2003
Lexicon Genetics Broadens Patent Portfolio with New Patent on Creation of Knockout Mice
11/17/2003
Alan S. Nies, M.D. Elected to Lexicon Genetics Board of Directors
11/14/2003
Lexicon Genetics Added to NASDAQ Biotechnology Index
11/11/2003
Lexicon Discovers Gene to Control High Blood Pressure with Direct Link to Human Hypertension
«
Start
Prev
11
12
13
14
15
16
17
18
19
20
Next
End
»
Page 17 of 32